Business Standard

Snoop Dogg-backed medical marijuana company seeks Big Pharma funding

Bank of America Merrill Lynch estimates the European legal cannabis market could be worth around $60 billion a year by 2026

Long-term marijuana use disrupts brain's reward process

Representative Image.

The U.K. medical marijuana company backed by Snoop Dogg’s venture firm is targeting Big Pharma in its latest fundraising round and said drugmakers getting involved in cannabis would help validate the burgeoning European industry.

Oxford Cannabinoid Technologies Ltd. is working on breaking cannabis extractions down to their constituent parts then investigating potential uses in immunology, oncology, neurology and pain relief, OCT Chairman Neil Mahapatra said. The firm is seeking about $50 million, which should be enough to finance its work until about 2024, he said. For now, no public stock offering is planned until around that time, although a listing could

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 27 2019 | 7:51 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to